167 related articles for article (PubMed ID: 34998000)
1. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
Eldahshan RM; Ashry WMO; Elsaie ML
J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
[TBL] [Abstract][Full Text] [Related]
2. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
Rageh RM; Hewedy ES; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
5. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
7. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Intralesional
Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in cutaneous warts: comparative clinical Study between MMR vaccine, tuberculin, and BCG Vaccine.
Shaker ESE; Doghim NN; Hassan AM; Musafa SS; Fawzy MM
J Cosmet Dermatol; 2021 Aug; 20(8):2657-2666. PubMed ID: 33410249
[TBL] [Abstract][Full Text] [Related]
10. Intralesional measles-mumps-rubella is associated with a higher complete response in cutaneous warts: a systematic review and meta-analysis of randomized controlled trial including GRADE qualification.
Vania R; Pranata R; Tan ST
J Dermatolog Treat; 2021 Dec; 32(8):1010-1017. PubMed ID: 31985307
[TBL] [Abstract][Full Text] [Related]
11. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
Nofal A; Alakad R
J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
[TBL] [Abstract][Full Text] [Related]
12. Comparative clinical study of the efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts.
Shaldoum DR; Hassan GFR; El Maadawy EH; El-Maghraby GM
J Cosmet Dermatol; 2020 Aug; 19(8):2033-2040. PubMed ID: 31925891
[TBL] [Abstract][Full Text] [Related]
13. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
14. Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature.
Al-Qassabi AM; Al-Farsi F
Sultan Qaboos Univ Med J; 2022 Aug; 22(3):413-416. PubMed ID: 36072081
[TBL] [Abstract][Full Text] [Related]
15. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
Nofal A; Alakad R; Fouda I; Fawzy MM
J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
[TBL] [Abstract][Full Text] [Related]
16. Intralesional immunotherapy for pediatric warts: A review.
Fields JR; Saikaly SK; Schoch JJ
Pediatr Dermatol; 2020 Mar; 37(2):265-271. PubMed ID: 31930595
[TBL] [Abstract][Full Text] [Related]
17. Comment on "intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts".
Mungmunpuntipantip R; Wiwanitkit V
J Cosmet Dermatol; 2022 Dec; 21(12):7211. PubMed ID: 35621238
[No Abstract] [Full Text] [Related]
18. Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts.
Nofal AA; Elkholy BM; Abd-Elmonsef ER; Nofal HO
Dermatol Ther (Heidelb); 2022 May; 12(5):1225-1237. PubMed ID: 35449500
[TBL] [Abstract][Full Text] [Related]
19. Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study.
Zaky MS; Atallah RB; Mohyeldeen AMS; Elsaie ML
Sci Rep; 2024 Jan; 14(1):288. PubMed ID: 38167543
[TBL] [Abstract][Full Text] [Related]
20. A review of intralesional wart therapy.
Muse ME; Stiff KM; Glines KR; Cline A; Feldman SR
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
